Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Indian IP and liabilities law barrier to pharma RnD investment

      Indian IP and liabilities law barrier to pharma RnD investment

      Medical Dialogues Bureau13 May 2018 9:06 AM IST
      BOSTON: India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, especially from the US, that...
      ASSOCHAM urges greater utilisation of technology in pharmaceuticals

      ASSOCHAM urges greater utilisation of technology in pharmaceuticals

      Medical Dialogues Bureau13 May 2018 9:00 AM IST
      New Delhi: Advanced, affordable and accessible solutions are the only way forward towards intensifying the innovations in the Indian pharmaceutical...
      Zydus Cadila gets USFDA nod for Carbidopa tablets

      Zydus Cadila gets USFDA nod for Carbidopa tablets

      Medical Dialogues Bureau12 May 2018 12:06 PM IST
      Zydus Cadila has received final approval from the US health regulator to market Carbidopa tablets, used for treating symptoms of Parkinson's disease....
      FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

      FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

      Medical Dialogues Bureau12 May 2018 12:00 PM IST
      The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
      Fortis Takeover Bid: IHH, Manipal-TPG disappointed With Board Decision

      Fortis Takeover Bid: IHH, Manipal-TPG disappointed With Board Decision

      Medical Dialogues Bureau12 May 2018 11:57 AM IST
      New Delhi: After losing out to Munjal-Burman combine in the race for Fortis, Malaysia's IHH Healthcare today said it is looking to speak to the...
      Invest more in RnD, develop new markets to boost pharma exports: Prabhu to industry

      Invest more in RnD, develop new markets to boost pharma exports: Prabhu to industry

      Medical Dialogues Bureau12 May 2018 10:56 AM IST
      New Delhi: Commerce and Industry Minister Suresh Prabhu today asked pharma firms to increase R&D investments and develop new markets to boost the...
      Bharat Biotech receives National Technology Award for ROTAVAC® from the President of India

      Bharat Biotech receives National Technology Award for ROTAVAC® from the President of India

      Medical Dialogues Bureau12 May 2018 10:50 AM IST
      Hyderabad: Bharat Biotech announces the receipt of the National Technology Award for 2018 from the Technology Development Board, Govt of India. This...
      Chinese medical devices maker forays into Indian market

      Chinese medical devices maker forays into Indian market

      Medical Dialogues Bureau12 May 2018 9:06 AM IST
      Hyderabad: China-based Lepu Medical Technology (Beijing) Co. Ltd today said itis all set to make its foray into Indian medical devices and equipment...
      Aurobindo Pharma LLC recalls over 1.5 million injections from

      Aurobindo Pharma LLC recalls over 1.5 million injections from

      Medical Dialogues Bureau12 May 2018 9:05 AM IST
      Hyderabad: Auromedics Pharma LLC,a US subsidiary of Aurobindo Pharma, has initiated voluntary recall of over 1.5 million bags of different anti biotic...
      Battle For Fortis: Munjal-Burmans emerge Victorious

      Battle For Fortis: Munjal-Burmans emerge Victorious

      Medical Dialogues Bureau11 May 2018 3:36 PM IST
      New Delhi: The board of Fortis Healthcare today recommended the binding offer of the Munjal-Burmans combine to the shareholders after 18 months of...
      Cipla partners MannKind for marketing, distribution of Afrezza in India

      Cipla partners MannKind for marketing, distribution of Afrezza in India

      Medical Dialogues Bureau11 May 2018 10:58 AM IST
      New Delhi: Drug firm Cipla today said it has entered into an exclusive marketing and distribution agreement with US-based MannKind Corporation for...
      Anondita Healthcare joins hands with Maharashtra, Karnataka Government

      Anondita Healthcare joins hands with Maharashtra, Karnataka Government

      Medical Dialogues Bureau11 May 2018 10:56 AM IST
      New Delhi: Anondita Healthcare, India's leading manufacturer of condoms and surgical gloves, has recently signed significant contracts with...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok